39464168|t|Intranasal Dexmedetomidine-Esketamine Combination Premedication versus Monotherapy for Reducing Emergence Delirium and Postoperative Behavioral Changes in Pediatric Tonsillectomy and/or Adenoidectomy: A Randomized Controlled Trial.
39464168|a|Purpose: Emergence delirium and postoperative negative behavioral changes (PNBC) are common complications in pediatric anesthesia. This study evaluated whether intranasal premedication combining dexmedetomidine and esketamine more effectively reduces these complications compared to either drug alone in children undergoing tonsillectomy and/or adenoidectomy with sevoflurane anesthesia. Patients and Methods: This randomized, double-blind trial involved 198 children aged 2-5 years undergoing tonsillectomy and/or adenoidectomy. Participants received intranasal premedication with either dexmedetomidine (2 mug/kg), esketamine (1 mg/kg), or their combination (dexmedetomidine 1 mug/kg plus esketamine 0.5 mg/kg). The primary outcome was the incidence of emergence delirium, defined as a Pediatric Anesthesia Emergence Delirium (PAED) scale score >= 10. Secondary outcomes included the incidence of PNBC, sedation depth, easiness of separation from parents, acceptance of the mask for induction, emergence time, postoperative pain score, parental satisfaction, and adverse events. Results: The combination premedication significantly reduced emergence delirium incidence (9.4%) compared to esketamine alone (38.1%; relative risk [RR] 0.25, 95% confidence interval [CI] 0.11-0.57, p < 0.001), but not compared to dexmedetomidine alone (17.2%; RR 0.55, 95% CI 0.21-1.39, p = 0.193). PNBC incidence at day 7 was lower with the combination (28.1%) versus dexmedetomidine (48.4%; RR 0.58, 95% CI 0.36-0.93, p = 0.018), but not significantly different from esketamine alone (20.6%; RR 1.38, 95% CI 0.74-2.58, p = 0.326). The combination also provided significantly superior sedation, improved ease of separation from parents, better acceptance of the mask for induction, shorter emergence time, and higher parental satisfaction than both monotherapies. Conclusion: In children undergoing tonsillectomy and/or adenoidectomy with sevoflurane anesthesia, intranasal dexmedetomidine-esketamine premedication more effectively reduces emergence delirium compared to esketamine alone and PNBC compared to dexmedetomidine alone. This combination also improves sedation, shortens emergence times, and enhances parental satisfaction compared to monotherapy without significant adverse effects. Trial Registration: The Chinese Clinical Trial Registry, ChiCTR2300076709.
39464168	11	26	Dexmedetomidine	Chemical	MESH:D020927
39464168	27	37	Esketamine	Chemical	MESH:C000629870
39464168	96	114	Emergence Delirium	Disease	MESH:D000071257
39464168	186	199	Adenoidectomy	Disease	
39464168	241	259	Emergence delirium	Disease	MESH:D000071257
39464168	264	305	postoperative negative behavioral changes	Disease	MESH:D064726
39464168	307	311	PNBC	Disease	MESH:D064726
39464168	427	442	dexmedetomidine	Chemical	MESH:D020927
39464168	447	457	esketamine	Chemical	MESH:C000629870
39464168	577	590	adenoidectomy	Disease	
39464168	596	607	sevoflurane	Chemical	MESH:D000077149
39464168	620	628	Patients	Species	9606
39464168	747	760	adenoidectomy	Disease	
39464168	821	836	dexmedetomidine	Chemical	MESH:D020927
39464168	849	859	esketamine	Chemical	MESH:C000629870
39464168	893	908	dexmedetomidine	Chemical	MESH:D020927
39464168	923	933	esketamine	Chemical	MESH:C000629870
39464168	987	1005	emergence delirium	Disease	MESH:D000071257
39464168	1041	1059	Emergence Delirium	Disease	MESH:D000071257
39464168	1131	1135	PNBC	Disease	MESH:D064726
39464168	1244	1262	postoperative pain	Disease	MESH:D010149
39464168	1374	1392	emergence delirium	Disease	MESH:D000071257
39464168	1422	1432	esketamine	Chemical	MESH:C000629870
39464168	1544	1559	dexmedetomidine	Chemical	MESH:D020927
39464168	1613	1617	PNBC	Disease	MESH:D064726
39464168	1683	1698	dexmedetomidine	Chemical	MESH:D020927
39464168	1783	1793	esketamine	Chemical	MESH:C000629870
39464168	2135	2148	adenoidectomy	Disease	
39464168	2154	2165	sevoflurane	Chemical	MESH:D000077149
39464168	2189	2204	dexmedetomidine	Chemical	MESH:D020927
39464168	2205	2215	esketamine	Chemical	MESH:C000629870
39464168	2255	2273	emergence delirium	Disease	MESH:D000071257
39464168	2286	2296	esketamine	Chemical	MESH:C000629870
39464168	2307	2311	PNBC	Disease	MESH:D064726
39464168	2324	2339	dexmedetomidine	Chemical	MESH:D020927
39464168	Negative_Correlation	MESH:C000629870	MESH:D000071257
39464168	Positive_Correlation	MESH:D000077149	MESH:D000071257
39464168	Negative_Correlation	MESH:D020927	MESH:D064726
39464168	Cotreatment	MESH:C000629870	MESH:D020927
39464168	Negative_Correlation	MESH:D020927	MESH:D000071257

